Premier Biomedical, Inc. (BIEI)

OTCMKTS: BIEI · Delayed Price · USD
0.0032
-0.0002 (-5.88%)
Jan 13, 2023, 4:00 PM EST - Market closed
Market Cap 5.05M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out n/a
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,357,031
Open 0.0035
Previous Close 0.0034
Day's Range 0.0030 - 0.0035
52-Week Range 0.0011 - 0.0069
Beta -4.63
Analysts n/a
Price Target n/a
Earnings Date n/a

About BIEI

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca... [Read more]

Sector Healthcare
Founded 2010
Country United States
Stock Exchange OTCMKTS
Ticker Symbol BIEI
Full Company Profile

News

Premier Biomedical Inc. (OTC PINK: BIEI), now known as Nova-Graphene Ballistics, Inc., Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology

Premier, N/K/A Nova-Graphene Ballistics, Inc., has Acquired the Rights to Use, Within the United States, this Proprietary Technology for Lightweight, Extremely Protective, Graphene Ballistic Plate Pro...

1 month ago - GlobeNewsWire